| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-07 |